MT-40x
Tumor‑targeting antibodies for solid tumors
PreclinicalActive
Key Facts
About MabTics
Innovative antibody platform focused on vessel normalization for oncology, vascular, and eye diseases.
View full company profileTumor‑targeting antibodies for solid tumors
Innovative antibody platform focused on vessel normalization for oncology, vascular, and eye diseases.
View full company profile